901 results on '"Murphy, Gerald P."'
Search Results
202. Hormonal Therapies in Prostatic Cancer.
203. Evaluation of Chemotherapy in a Murine Model for Bladder Cancer.
204. Growth Characteristics of Murine Tumors: Neuroblastoma, Renal Cell Adenocarcinoma, Wistar/Furth Wilms' after Storage in a Cryopreservation System.
205. Treatment of Murine Wilms' Tumor with Chemotherapy after Intramuscular Tumor Inoculation and Amputation.
206. Evaluation of Combination Chemotherapy in Wistar/Furth Rats Bearing Transplantable Wilms' Tumor.
207. Workshop on Response Criteria and Evaluation of the Stable Disease Category in Carcinoma of the Prostate, Breast, and Large Bowel.
208. Effect of Tamoxifen Citrate on a Murine Renal Cell Adenocarcinoma.
209. Evaluation of the Chronic Hepatic Toxicity of 6-Mercaptopurine in the Wistar Rat.
210. Management and Survival of Adenocarcinoma of the Rectum in the United States: Results of a National Survey by the American College of Surgeons.
211. Long-Term Survival Determinants in Wilms' Tumor.
212. A Simplified Purification Procedure for Human Prostate Antigen.
213. Failure of Actinomycin D Entrapped in Liposomes to Prolong Survival in Renal Cell Adenocarcinoma-Bearing Mice.
214. Effect of Postoperative Chemotherapy and Radiotherapy on the Survival of Subcutaneously Implanted Furth Wilms' Tumor.
215. Chemotherapy of Advanced, Hormonally Resistant Prostatic Carcinoma.
216. Measurements of Prolactin and Androgens in Patients with Prostatic Diseases.
217. Correlation of B-Scan Ultrasonic Laminography with Bilateral Selective Hypogastric Arteriography and Lymphography in Bladder Tumors.
218. Prostate cancer: an update.
219. Testicular cancer.
220. Prostate Cancer: continuing progress.
221. Prostate cancer: progress and change.
222. Prostate cancer.
223. Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA).
224. Immunoscintigraphy of prostatic cancer: Preliminary results with 111in-labeled monoclonal antibody 7E11-C5.3 (CYT-356).
225. Studies on a Nitrogen Mustard of Estradiol in Dogs and Rats1.
226. Study on the Growth Limiting Mechanism in the Rat Ventral Prostate.
227. CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells.
228. Application of the differential hybridization of Atlas™ human expression arrays technique in the identification of differentially expressed genes in human glioblastoma multiforme tumor tissue.
229. Cloning, sequence, and developmental expression analysis of C4-2, a potential brain tumor-suppressor gene.
230. Characterization of C4-2 as a tumor-suppressor gene in human brain tumors.
231. Prostate cancer in blacks: An update from the American college of surgeons' patterns of care studies.
232. Creatine kinase isoenzyme (CK-BB) by RIA as a follow-up marker in stage D cancer of the prostate: Comparison with PAP RIA.
233. Comparision of immunologic and enzymatic assay of prostatic acid phosphatase for follow-up and assessment of clinical status of stage d prostate cancer.
234. Clinical aspects of steroid hormone receptors in human renal cell carcinoma.
235. The effects of cholestyramine, colestipol, and ADR-132 on the rat prostate and dunning R-3327 adenocarcinoma.
236. Results of the national soft-tissue sarcoma registry.
237. Adenosine-aminohydrolase activity in the erythrocytes, lymphocytes, and plasma of healthy subjects and kidney transplant recipients.
238. Erythropoietin levels in wistar-furth Wilms' tumor rats.
239. Enterprise professional development – evaluating learning
240. Relapsing disease
241. THE RHESUS MONKEY AS A RENAL TRANSPLANT MODEL.
242. Carcinoembryonic antigen in patients with tumors of the urogenital tract.
243. Adrenalectomy and hypophysectomy in advanced prostatic carcinoma.
244. III. Service. Service for the comprehensive cancer center.
245. Erythropoietin levels in patients with renal tumors or cysts.
246. Comparison of total and prostatic fraction serum acid phosphatase levels in patients with differentiated and undifferentiated prostatic carcinoma.
247. The diagnosis and treatment of hypernephroma.
248. RADIOISOTOPIC EVALUATION OF RENAL ALLOGRAFTS WITH THE DIGITAL AUTOFLUOROSCOPE.
249. THE JUXTAGLOMERULAR APPARATUS IN RENAL ALLOGRAFT REJECTION: HISTOLOGICAL AND ULTRASTRUCTURAL STUDY.
250. A BEHAVIORAL BIOASSAY METHOD USING MATERIAL FROM A UREMIC PATIENT.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.